Abeona Therapeutics
Manufacturing · Ohio, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
6555 Carnegie Ave Fl 4, Cleveland, Ohio,...Phone Number
(646) 813-4701Website
www.abeonatherapeutics.comRevenue
$14.5 MillionStock Symbol
ABEOIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Abeona Therapeutics
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of advanced cell and gene therapies for serious diseases with significant unmet medical needs. The company is dedicated to developing innovative treatment approaches that address the underlying causes of rare and complex disorders rather than only managing symptoms.Explore more
Abeona Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Abeona Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Abeona Therapeutics launches new products
Earning: See what the market has to say on Abeona Therapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Abeona Therapeutics
Click to see if Abeona Therapeutics had a recent Job posting/layoffs
Check out if Abeona Therapeutics is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Abeona Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Abeona Therapeutics has new funding data
Check if Abeona Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Abeona Therapeutics
Compare insights from companies similar to Abeona Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Abeona Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Abeona Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abeona Therapeutics.
Abeona Therapeutics financials insights
Gather financial insights about Abeona Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Other Financing Round
$3.6M
2015
Share Placement
$8.5M
2017
Grant
$13.8M
Share Placement
$92M
2019
Stock Offering
$103.5M
2020
Debt
$1M
2022
Other Financing Round
$35M
2023
Share Placement
$25M
Abeona Therapeutics Tech Stack
A closer look at the technologies used by Abeona Therapeutics
Most Recent Scoops
Person-Based
Earnings
Abeona Therapeutics has reported cash equivalents and short-term investments totaling $146.8 million as of June 30, 2026, with the company focused on disciplined capital allocation as it works toward a sustainable cash flow positive business model.
Spending/Investment, Financial Planning, Business Finance, Finance, Financial Operations, Financial Strategy
Earnings
Abeona Therapeutics has reported net ZEVASKYN revenue of $11.4 million for Q2 of fiscal 2026 ended June 30, 2026, representing a quarter-over-quarter increase of 31%, or $2.7 million, compared to $8.7 million in Q1 2026, with revenue recognized for four of the five patients treated during the quarter as one batch had cell yield below the threshold for revenue recognition.
Earnings, Finance
Person-Based
Product Launch, Sales
Project
Contracts
Abeona Therapeutics News & Media
Abeona Therapeutics Inc. (ABEO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Abeona Therapeutics Inc. (ABEO) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDTCompany ParticipantsVishwas Seshadri...Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®
CLEVELAND, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing genetic medicines for serious diseases with high unmet need, today announced the activation of University of Florida Health (UF Health) in Gainesville, Florida, as the eighth Qualified Treatment Center (QTC) for the administration of ZEVASKYN (prademagene zamikeracel) gene-modified cellular sheets. ZEVASKYN is the first and only autologous gene-modified cINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Abeona Therapeutics Inc. - ABEO
NEW YORK, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Abeona Therapeutics Inc. (“Abeona” or the “Company”) (NASDAQ: ABEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences
CLEVELAND, Sept. 02, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that members of its management team will participate in upcoming investor conferences in September 2026:
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Abeona Therapeutics
Sign Up For FreeTo access detailed company insights
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on the research, development, manufacturing, and commercialization of advanced cell and gene therapies for serious diseases with significant unmet medical needs. The company is dedicated to developing innovative treatment approaches that address the underlying causes o... Read More
